Intervention to Increase Compliance to a Gluten Free Diet

  • Research type

    Research Study

  • Full title

    Intervention to increase compliance to a gluten free diet in patients with coeliac disease.

  • IRAS ID

    214859

  • Contact name

    Humayun Muhammad

  • Contact email

    muhammah@roehampton.ac.uk

  • Sponsor organisation

    Roehampton University

  • Clinicaltrials.gov Identifier

    LSC 16/ 190., University of Roehampton, London

  • Duration of Study in the UK

    1 years, 0 months, 31 days

  • Research summary

    Coeliac disease (CD) is a disorder of the gastrointestinal system where a reaction to gluten (found in wheat and related products) leads the inflammation of the inner lining of the small bowel. This in turns leads to mal-absorption resulting in anaemia, and may lead to skin disorder, cancer and bone disease. Avoiding gluten is the only practical way to counteract this reaction. Patients with coeliac disease are offered strict Gluten free diet (GFD).

    The GFD is not easy to follow and there are several compliance related issues for patients with CD. There is evidence to suggest that patients following a GFD have less disease related complications. Compliance is low in Asian patients as shown by one previous study in 2004 (Butterworth et; al). There is only one Australian study (Sainsbury and Mulan 2013) which designed and administered an intervention to increase compliance to GFD in CD.

    In a previous study we conducted an interview with patients non-compliant to the GFD, information provided by the patients has informed the design of our intervention, a telephonic clinic, which is also considered cost effective. This will be the first intervention which will include ethnic minority who does not speak English, the telephonic clinic will be conducted in English and ethnic languages. Prior to the telephonic interview and up to 12 months afterwards participants will periodically receive questionnaires to evaluate the impact of the telephonic interview on compliance to the GFD.

    We have identified 700 patients, in the Dudley area, who could be invited to participate in the study.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    17/EM/0056

  • Date of REC Opinion

    22 Feb 2017

  • REC opinion

    Further Information Favourable Opinion